In this experiment, they found that PD‐L1 antibody‐mediated immune checkpoint blockage therapy produces a curative effect on breast cancer, and combining PDT with PD‐L1 antibody effectively eliminates the tumor in situ and prevents the metastasis of the tumor. The gene discussed is CD274; the disease is neoplasm.